翻訳と辞書 |
Karin M. Hehenberger : ウィキペディア英語版 | Karin M. Hehenberger
Karin M. Hehenberger, M.D., Ph.D. is a physician, investor, business executive, and diabetes expert, known for her work in the field of biotechnology. She has written numerous articles on biotechnology that have been published in peer review journals and worked as an executive for different biotechnology companies and investment firms. She is a faculty member in the department of Molecular Medicine at the Karolinska Institute where she also obtained her M.D. and a Ph.D. in molecular medicine.〔 She has lectured on the topics of autoimmune diseases, diabetes, molecular medicine and industry challenges as well as provided commentary for Fox News, Good Morning America Health, New York One, the USA Today〔 and Forbes. ==Early life and education==
Hehenberger is originally from Sweden and played for the Swedish National tennis team. At the age of 16, she was playing tennis internationally when she was diagnosed with Type 1 diabetes, ending her tennis career. Her experience with diabetes led her to pursue a career fighting autoimmune diseases.〔 Hehenberger attended the Karolinska Institutet in Stockholm, Sweden, where she earned her M.D. and Ph.D. in molecular medicine.〔 She went on to a post-doctoral fellowship with the Joslin Diabetes Center at Harvard Medical School. In 2009, she received a kidney transplant from her father, after her kidneys had less than 10 percent total capacity, and in 2010 she received a transplanted cadaver pancreas. The kidney surgery saved her from needing dialysis, while the pancreas surgery rendered her free of diabetes, no longer needing to inject insulin.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Karin M. Hehenberger」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|